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Abstract
 
Memory T cells can be divided into central–memory (T
 
CM
 
) and effector–memory (T
 
EM
 
) cells,
which differ in their functional properties. Although both subpopulations can persist long term,
it is not known whether they are maintained by similar mechanisms. We used in vivo labeling
with deuterated glucose to measure the turnover of CD4
 

 
 T cells in healthy humans. The
CD45R0
 

 
CCR7
 

 
 T
 
EM
 
 subpopulation was shown to have a rapid proliferation rate of 4.7%
per day compared with 1.5% per day for CD45R0
 

 
CCR7
 

 
 T
 
CM
 
 cells; these values are equiv-
alent to average intermitotic (doubling) times of 15 and 48 d, respectively. In contrast, the
CD45RA
 

 
CCR7
 

 
 naive CD4
 

 
 T cell population was found to be much longer lived, being
labeled at a rate of only 0.2% per day (corresponding to an intermitotic time of approximately
1 yr). These data indicate that human CD4
 

 
 T
 
EM
 
 cells constitute a short-lived cell population
that requires continuous replenishment in vivo.
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Introduction
 
One factor contributing to immunological memory is the
much higher frequency of lymphocytes specific for the
priming antigen in the memory pool than among naive cells.
Long-term persistence of memory cells is achieved by a
combination of two processes: first, the long-term survival of
individual cells, and second, periodic cell division to balance
attrition through cell death. Both processes are dependent on
contact with MHC–peptide complexes and with cytokines
such as IL-15 and IL-7 (1). Current understanding of how
memory cell populations persist has been aided by studies in-
vestigating the kinetic behavior of T cells in various animal
species, including humans, which have shown that those
cells with a memory phenotype (CD45R0
 

 
 in humans)
exhibit a considerably higher rate of turnover than naive
phenotype T cells and have a relatively short lifespan, on the
order of weeks or months (2–7). However, memory T cells
are phenotypically and functionally heterogeneous, and it is
not known if rapid turnover applies to all memory cells.
A major subdivision among memory T cells is that between
central–memory (T
 
CM
 
) and effector–memory (T
 
EM
 
) cells
(8). These subpopulations, which are identified among
human CD45R0
 

 
 T cells as being CCR7
 

 
CD62L
 

 
 or
CCR7
 

 
CD62L
 

 
 respectively, exhibit distinct functional
properties. T
 
CM
 
 cells enter LNs through high endothelial
venules and recirculate primarily between blood and
lymph, whereas T
 
EM
 
 cells migrate preferentially from the
blood into peripheral tissues such as the lung or intestinal
mucosa (9–11). In addition, T
 
EM
 
 cells express effector activ-
ity (e.g., cytolytic activity or secretion of cytokines such as
IFN-
 

 
, IL-4, or IL-5) more rapidly than T
 
CM
 
 cells upon
restimulation with antigen (8, 9, 12), although some studies
suggest that this distinction may be less clear for memory
CD8
 

 
 T cells (13). On this basis, T
 
CM
 
 and T
 
EM
 
 cells have
been proposed to play complementary roles in the secondary
response to infection, with T
 
EM
 
 cells providing a rapid effector
response at sites of pathogen entry and T
 
CM
 
 cells serving as
an expanded pool of precursors that can proliferate in the
secondary lymphoid organs to rapidly generate large num-
bers of effector cells (8).
Although both T
 
CM
 
 and T
 
EM
 
 CD4
 

 
 populations appear
to persist long term in humans (8), the kinetic behavior of
the cells which comprise these subpopulations is unknown.
To measure turnover of human T
 
CM
 
 and T
 
EM
 
 CD4
 

 
 cells,
we used 
 
2
 
H-glucose, which is incorporated into DNA via
the de novo nucleotide synthesis pathway, to label dividing
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cells in vivo (14). The results show a clear difference in
turnover rates between these subpopulations, with T
 
EM
 
CD4
 

 
 cells being much shorter lived. The implications for
maintenance of T cell memory are discussed.
 
Materials and Methods
 
In Vivo Labeling with 
 
2
 
H
 
2
 
-Glucose.
 
Six young healthy volun-
teers (ranging from 19 to 30 yr of age) were given a primed 24-h
i.v. infusion of 
 

 
1 g/kg 6,6-
 
2
 
H
 
2
 
-glucose (Cambridge Isotopes).
During this time, their diet was restricted to small, low energy
meals. For measurement of plasma glucose 
 
2
 
H enrichment, blood
was taken at 
 

 
4-hr intervals during infusion. For estimation of
 
2
 
H enrichment in cell DNA, 50 ml heparinized blood samples
were taken at 3, 4, 10, and 21 d after commencement of the infu-
sion. All subjects gave written informed consent under protocols
approved by the Local Research Ethics Committee.
 
Cell Sorting.
 
PBMCs were isolated from blood by Ficoll-
Paque (Amersham Biosciences) density gradient centrifugation
and stained (10
 
7
 
/ml in PBS 
 
 
 
0.2% BSA) in one of three ways.
(i) Mouse anti–human CCR7 (IgM) (BD Biosciences), goat anti–
mouse IgM F(ab
 

 
)
 
2
 
-RPE (Southern Biotechnology Associates
Inc.), anti–CD45RA-RPE-CY5 (Serotec Ltd.) and anti–
CD4–APC (BD Biosciences). (ii) Anti–human CCR7, anti-IgM
(Fab)
 
2
 
-PE, anti-CD45RA-biotin (BD Biosciences), streptavidin-
PerCP (BD Biosciences), and anti–CD4–APC. (iii) Anti–human
CCR7, anti-IgM (Fab)
 
2
 
-PE, anti–CD4-biotin (BD Biosciences),
streptavidin-PerCP, anti-CD45R0-allophycocyanin (CALTAG).
Similar results were obtained using any of these staining strate-
gies. Stained cells were sorted using a Moflow flow cytometer
(Cytomation). Typical purities and cell yields for the three major
subpopulations (naive, T
 
CM
 
, T
 
EM
 
) were 85–98% and 1–6 
 

 
 10
 
6
 
,
respectively; much smaller numbers of RA
 

 
7
 

 
 cells were ob-
tained (
 

 
4 
 

 
 10
 
5
 
), and purity was usually lower than for the
other three populations.
 
Analysis of Deuterium Enrichment and Modeling of Proliferation.
 
Enrichment of deuterium in DNA was assayed essentially as de-
scribed previously (7, 15). Briefly, cellular DNA was extracted
and digested enzymatically to deoxynucleosides. Purified deoxy-
adenosine was converted to its aldononitrile triacetate derivative
by reaction with hydroxylamine/pyridine and acetic anhydride.
The resulting derivative was analyzed in triplicate by gas chroma-
tography mass spectrometry, monitoring ions m/z 198 and 200
(SIM mode in PCI, HP-225 column, HP 6890/5973 GCMS;
Hewlett Packard). Typical precision of reproducibility of the
M
 

 
2 to M
 

 
0 ratio was 
 

 
0.02%. Plasma glucose enrichment
was measured using the same derivatization (m/z 328 and 330).
For each subject, mean glucose enrichment for the 24-h labeling
period was derived from the area under the curve for the enrich-
ment time profile. Mean glucose enrichment ranged from 18 to
29% (mean 24%).
Results were expressed as the fraction of labeled cells (F)
present on each day, given by the ratio of the enrichment of label
in DNA (E) and the precursor enrichment (b, the mean glucose
enrichment over 24 h 
 

 
 0.65) (14). The magnitude of the peak
value for F represents a crude measure of the cellular proliferation
rate. Data was modeled as previously described (7) (Sigmaplot
v8.02; SPSS), to estimate the rate of proliferation during labeling,
p, and subsequent rate of loss of labeled cells, d
 
*
 
, taking into ac-
count cell death between the end of labeling and first sampling on
day 3 and assuming no changes in pool sizes, according to the fol-
lowing equations:
where 
 
t
 
 is time and 
 

 
 is the length of the labeling period.
In this model, no assumption of equality between p and d
 
*
 
 has
been made; p represents the average proliferation rate of the whole
population, whereas d
 
*
 
 refers only to labeled cells (i.e., cells which
divided during the labeling period). For a kinetically heteroge-
neous population, even one at steady-state, these two rates will not
be the same, as discussed elsewhere (7). Where the day 3 value fell
below the day 4 value for the same lymphocyte pool, it was as-
sumed that the day 3 value lay within the lag phase between divi-
sion and appearance in the circulation, and it was excluded from
modeling. Where proliferation is expressed as doubling time (t
 
2
 
) or
disappearance as half-life (t
 
1/2
 
), these were calculated as ln2/p and
ln2/d, respectively. Data are expressed as means. Comparisons be-
tween groups were made by Student’s 
 
t
 
 test.
 
Results and Discussion
 
To measure T cell turnover in vivo, healthy volunteers
were infused with 
 
2
 
H-labeled glucose for 24 h, and enrich-
ment of 
 
2
 
H in the DNA of isolated subpopulations of pe-
ripheral blood lymphocytes was determined at several time
points. Day 3 was chosen as the earliest time point since
previous work has shown that the appearance of labeled T
cells in the blood peaks at 
 

 
3–4 d after starting the infusion
(7). CD4
 

 
CD3
 

 
 cells were subdivided by cell sorting into
four populations: CD45R0
 

 
 (or CD45RA
 

 
) CCR7
 

 
T
 
CM
 
 cells, CD45R0
 

 
 (or CD45RA
 

 
) CCR7
 

 
 T
 
EM
 
 cells,
CD45R0
 

 
 (or CD45RA
 

 
) CCR7
 

 
 naive cells and
CD45R0
 

 
 (or CD45RA
 

 
) CCR7
 

 
 cells (referred to as
RA
 

 
7
 

 
 cells). Lack of CCR7 expression on the latter sub-
set, which represents a small fraction of total CD45RA
 

 
CD4
 

 
 T cells, suggests that RA
 

 
7
 

 
 cells are not naive; an-
tigen-primed cells have been identified previously among
CD45RA
 

 
 CD4
 

 
 cells based on an absence of CD31 ex-
pression (16). On average, these subpopulations repre-
sented 
 

 
21% (T
 
CM), 12% (TEM), 64% (naive), and 3%
(RA7) of total peripheral blood CD4 T cells in the
subjects studied.
From the measurement of 2H enrichment in DNA, the
proportion of cells in each subpopulation that was labeled at
the different time points was calculated, and these values are
shown in Fig. 1. Based on the results, several points can be
made. First, labeling of naive cells was extremely low, con-
firming previous work showing that there is little prolifera-
tion within this subpopulation (2–7). Second, labeling of
TEM cells occurred at a substantially higher rate than for TCM
cells. This was observed clearly in five of the six subjects
studied. In the sixth subject (C15), similar rates of labeling
were observed for TEM and TCM cells, which appeared to be
due to a higher than average labeling of TCM cells in this in-
dividual. Third, RA7 cells showed a relatively rapid rate
of labeling, consistent with the view that these cells are not
naive but rather are antigen-primed; the exact relationship
F t( ) p
d∗
---- 1 ed∗t–( )      t ≤     during the labeling period=
F t( ) p
d∗
---- 1 ed∗–( )ed∗ t –( )  t >   after the labeling period=
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between these cells and TCM or TEM cells remains to be de-
fined. Peak height values (the maximum measured fraction
of labeled cells) for each subpopulation are summarized in
Table I. Mean values were higher in CCR7 than CCR7
populations for both CD45R0 and CD45RA cells.
To determine the rates of proliferation (p) and disappear-
ance (d*) for the various cell subpopulations, curves were
fitted to the data based on the fraction of labeled cells de-
tected at each time point (Fig. 1). Note that in modeling the
data it was assumed that maximal labeling was present at
24 h (i.e., at the cessation of 2H infusion) and that label dis-
appeared exponentially thereafter with a disappearance rate
constant, d*; this model takes into account cell death be-
tween the end of labeling and first sampling on day three.
As shown in Table II, p was significantly higher for TEM
than TCM cells. For the five subjects where this was the case,
p for TEM cells was on average five times of that of p for
TCM cells; TEM and TCM cells had roughly equivalent prolif-
eration rates in the sixth subject. Overall, the average prolif-
eration rates for TCM and TEM cells were 1.5 and 4.7% per
day, respectively. From p, the average intermitotic time for
cells within that population (t2) can be calculated, yielding
values of 48 d for TCM cells and 15 d for TEM cells.
Disappearance rates, though more variable, were also
higher for TEM than TCM cells in five of the six subjects. On
average, the disappearance rates were 4.1% per day for TCM
cells and 11.3% per day for TEM cells (equivalent to half-
lives [t1/2] for disappearance of the cells of 17 and 6 d, re-
spectively). Note that d* is a measure of the disappearance
rate of labeled cells only, whereas p applies to all cells, ex-
plaining why d* can exceed p at steady-state (even though
d, the disappearance rate of the entire population, must
equal p). As discussed previously, several explanations can
be proposed for the relatively rapid disappearance of re-
cently divided cells (7). Although this was true for both
Figure 1. Kinetics of labeling of naive, TCM, TEM, and RA7 CD4
T cells after infusion of 2H-glucose. Subjects were infused with 2H-glu-
cose for 24 h starting from time 0, and the proportion of labeled cells (rel-
ative to total cells in each subpopulation) at different time points is shown
for CD45RA (left) and CD45R0 CD4 T cells (right). Data for
CCR7 and CCR7 cells are indicated by filled or open symbols, re-
spectively; error bars represent the SD of triplicate GCMS measurements.
Lines represent best-fit curves calculated based on the data points and as-
suming maximal labeling at 24 h.
Table I. Glucose Enrichment and Peak Fraction of Labeled Cells 
after 24 h 6,6-D2-Glucose
Peak fraction of labeled cellsb
Glucose 
enrichmenta
CD45R0 CD45RA
CCR7 CCR7 CCR7 CCR7
% 	 d % % % %
C09c 29 1.4 2.9 ND ND
C11d 25 0.8 6.1 0.2 ND
C12e 22 1.5 1.7 0.5 0.9
C13e 18 1.0 4.9 0.7 1.7
C14e 28 1.0 2.4 0.1 4.1
C15e 20 3.0 3.1 0.2 4.1
Mean 24 1.5   3.5f 0.3   2.7f
SD 5 0.8 1.7 0.2 1.6
aFrom area under curve of enrichment time profile.
bMaximal value for labeling expressed as F (fraction of labeled cells) mea-
sured in lymphocyte subpopulations at time points sampled. Cells were
sorted according to method ic, iid, or iiie (see Materials and Methods).
fP 
 0.05 for CCR7 versus CCR7 by paired Student’s t test.
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TEM and TCM cells in many subjects, it is notable that la-
beled TCM cells in two individuals exhibited negligible dis-
appearance rates, implying that some TCM cells can differ-
entiate into long-lived cells after division. In contrast, d*
was higher than p for TEM cells in all subjects.
For naive CD4 T cells, p was very low, 0.2% per day,
which converts to a t2 for the naive population of about a
year (Table II). This contrasts with the rapid proliferation
observed among RA7 cells, which had an average p of
3.3% per day (t2  21 d). The labeling that does occur
amongst truly naive CD4 T cells could reflect division of
precursors in the thymus and their release into the blood
over the time course of the analysis. Alternatively, some
proliferation of mature naive cells could occur in the sec-
ondary lymphoid organs, perhaps in response to contact
with homeostatic cytokines (17–21). Whichever the case,
however, it is evident that the contribution of cell division
to maintaining the naive CD4 T cell pool in young adults
is minimal.
In addition, the disappearance rate for the majority of
naive (CD45RACCR7) CD4 T cells was shown to
be extremely slow. In fact, we found that d* for
CD45RACCR7 cells in all subjects was too small to esti-
mate using this method. This contrasts with earlier results
showing a relatively rapid disappearance rate for labeled total
CD4CD45RA cells of 7% per day (7). This disparity
may be partly explained by the disproportionate contribution
of RA7 cells to labeling in the previous study, since la-
beled cells in this population disappear rapidly. The present
data are striking in their implication that human naive CD4
T cells can remain in interphase for extremely long periods
of time after their derivation from dividing precursors.
Overall, the relative quiescence of naive CD4 T cells
and rapid turnover of memory–phenotype cells reported
Table II. Proliferation and Disappearance Rates for TCM, TEM, Naive, and RA7 CD4 T Cells
Proliferation Disappearance
CCR7 CCR7 CCR7 CCR7
CD45R0
Subject p t2 p t2 d* t1/2 d* t1/2
%/day %/day days %/day days %/day days %/day days 
C09 1.15 60 5.01 14 11.53 6.0 16.16 4.3
C11 0.74 94 7.59 9 0.00 c 20.28 3.4
C12 1.05 66 2.27 31 0.00  8.00 8.7
C13 1.03 67 7.41 9 2.32 29.9 11.61 6.0
C14 1.00 69 2.83 24 3.20 21.7 6.56 10.6
C15 3.77 18 3.31 21 7.74 9.0 5.26 13.2
Mean 1.46 48 4.74a 15 4.13 17 11.31a 6
 SD 1.14 2.33 4.61 5.90
CD45RA
C11 0.16 433 NDb ND 0.00  ND ND
C12 0.37 187 0.84 83 0.00  0.00 
C13 0.11 630 2.51 28 0.00  10.35 6.7
C14 0.12 578 4.44 16 0.00  4.02 17.2
C15 0.20 347 5.56 12 0.00  8.95 7.7
Mean 0.19 361 3.34a 21 0.00  5.83a 12
SD 0.11 2.09 0.00 4.74
Values for proliferation (p) and disappearance (d*) rates were derived from the best fit curves applied to the data (see Materials and Methods). t2 and
t1/2 represent doubling time or half-life equivalents of p or d*, respectively; mean values for t2 and t1/2 are calculated from the mean values for p and
d*, respectively.
aP 
 0.05 for CCR7 versus CCR7 by paired Student’s t test.
bND indicates not determined because of inadequate data for model estimate.
c indicates t2 or t1/2 exceeds maximal value detectable (p or d* close to zero).
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here are in agreement with the general pattern of kinetic
behavior that has been observed for these cells in many dif-
ferent species. Our data show that TCM and TEM CD4 T
cells in humans have distinct rates of turnover, with TEM
cells typically being replaced at a much faster rate than TCM
cells. These results imply that an almost continuous input
of new cells is required to maintain the TEM CD4 T cell
population, which could have important implications for
vaccination given that TEM may serve to provide a rapid ef-
fector response to reinfection. At face value, it could be ar-
gued that the shorter lifespan observed for TEM cells in the
blood is simply a consequence of these cells having an abil-
ity to migrate rapidly and irreversibly into tissues. How-
ever, if one assumes that the number of TEM cells in tissues
is constant (rather than increasing) under steady-state con-
ditions, turnover of cells in the blood ultimately reflects
what is occurring in the total TEM population. Therefore, it
is evident from the rapid rate of production that there is
also a rapid rate of disappearance among TEM cells.
Several factors could contribute to differences in the ki-
netic behavior between TCM and TEM cells. First, their dis-
tinct patterns of migration make it likely that the extent to
which they contact cell division- and survival-inducing fac-
tors will differ (22). Second, it has been shown that TCM
and TEM cells exhibit intrinsic differences in their respon-
siveness to homeostatic cytokines (23). In particular, TEM
cells have higher cell surface expression of the IL-2/IL-
15R -chain, allowing them to proliferate in response to
lower concentrations of IL-15 than TCM cells. This differ-
ence could potentially account for the higher proliferation
rate among TEM cells. Third, TEM and TCM cells may also
differ in their intrinsic death rates or their ability to respond
to survival factors.
The present data should be considered with respect to
the uncertainty that exists in understanding the lineage re-
lationship between TCM and TEM cells, specifically whether
these cells represent independent subpopulations or merely
different activation states along a common differentiation
pathway. Previous work has shown that phenotypic con-
version can take place between TCM and TEM cells, suggest-
ing that one subpopulation could serve as a source for the
other; this has been observed for human CD4 cells, where
TCM cells can acquire characteristics of TEM cells in re-
sponse to stimulation through the TCR or by cytokines
(23), and in the reverse direction for mouse CD8 T cells,
where virus-specific TEM cells were shown to convert to
TCM cells with time after infection (24). In contrast, based
on analysis of T cell clonotypes present among TCM and
TEM CD8 T cells it was concluded that these cells repre-
sent independently regulated cell subpopulations in humans
(25). Although the present kinetic data could indicate that
TCM and TEM cells are maintained as separate pools with
distinct turnover rates, they are also compatible with a
model in which interconnection of TCM and TEM cells oc-
curs in both directions. According to this latter model, TEM
cells are maintained primarily through cell division, either
by existing TEM cells or by TCM cells that acquire a TEM
phenotype concomitant with division. Replacement of
TCM cells would occur through more limited cell division
among TCM cells that do not change phenotype and by
phenotypic reversion of TEM cells after these cells have re-
turned to a quiescent state. Future studies will be required
to distinguish between the two models.
Finally, these results raise the question of whether further
heterogeneity exists in the kinetic behavior of human
CD4 T cells. Previously, evidence for kinetic heterogene-
ity amongst antigen-primed human CD4 T cells had been
suggested by analysis of total memory–effector-phenotype
CD4 T cells (26). By using CCR7 as a marker, we were
able to demonstrate that there are distinct subpopulations
with differing turnover rates present in both CD45RA
and CD45R0 CD4 T cell populations. In the future, it
will be of interest to use other cell surface markers, for ex-
ample, those associated with recent activation, to character-
ize the in vivo behavior of additional cell populations.
We are grateful to Dr. B. Asquith for advice on modeling and to Dr.
M. Lipp for anti-CCR7 antibodies used in preliminary experiments.
This work was supported by the Edward Jenner Institute for
Vaccine Research (publication number 83). D.C. Macallan was
supported by a Medical Research Council Glaxo-Wellcome Clini-
cian Scientist fellowship; H. Ghattas was also supported by the
Medical Research Council.
Submitted: 20 February 2004
Accepted: 9 June 2004
References
1. Schluns, K.S., and L. Lefrancois. 2003. Cytokine control of
memory T-cell development and survival. Nat. Rev. Immu-
nol. 3:269–279.
2. Mackay, C.R., W.L. Marston, and L. Dudler. 1990. Naive
and memory T cells show distinct pathways of lymphocyte
recirculation. J. Exp. Med. 171:801–817.
3. Michie, C.A., A. McLean, A. Alcock, and P.C.L. Beverley.
1992. Lifespan of human lymphocyte subsets defined by
CD45 isoforms. Nature. 360:264–265.
4. Tough, D.F., and J. Sprent. 1994. Turnover of naive- and
memory-phenotype T cells. J. Exp. Med. 179:1127–1135.
5. Mohri, H., S. Bonhoeffer, S. Monard, A.S. Perelson, and
D.D. Ho. 1998. Rapid turnover of T lymphocytes in SIV-
infected Rhesus Macaques. Science. 279:1223–1227.
6. McCune, J.M., M.B. Hanley, D. Cesar, R. Halvorsen, R.
Hoh, D. Schmidt, E. Eieder, S. Deeks, S. Siler, and R.
Neese. 2000. Factors influencing T-cell turnover in HIV-1-
seropositive patients. J. Clin. Invest. 105:R1–R8.
7. Macallan, D.C., B. Asquith, A.J. Irvine, D.L. Wallace, A.
Worth, H. Ghattas, Y. Zhang, G.E. Griffin, D.F. Tough, and
P.C. Beverley. 2003. Measurement and modelling of human
T cell kinetics. Eur. J. Immunol. 33:2316–2326.
8. Sallusto, F., D. Lenig, R. Forster, M. Lipp, and A. Lanzavecchia.
1999. Two subsets of memory T lymphocytes with distinct
homing potentials and effector functions. Nature. 401:708–712.
9. Masopust, D., V. Vezys, A.L. Marzo, and L. Lefrancois.
2001. Preferential localization of effector memory cells in
nonlymphoid tissue. Science. 291:2413–2416.
10. Reinhardt, R.L., A. Khoruts, R. Merica, T. Zell, and M.K.
Rapid Turnover of Effector–Memory CD4 T Cells in Healthy Humans260
Jenkins. 2001. Visualizing the generation of memory CD4 T
cells in the whole body. Nature. 410:101–105.
11. Weninger, W., M.A. Crowley, N. Manjunath, and U.H. von
Andrian. 2001. Migratory properties of naive, effector, and
memory CD8 T cells. J. Exp. Med. 194:953–966.
12. Hislop, A.D., N.H. Gudgeon, M.F.C. Callan, C. Fazou, H.
Hasegawa, M. Salmon, and A.B. Rickinson. 2001. EBV-spe-
cific CD8 T cell memory: relationships between epitope
specificity, cell phenotype, and immediate effector function.
J. Immunol. 167:2019–2029.
13. Champagne, P., G.S. Ogg, A.S. King, C. Knabenhans, K.
Ellefsen, M. Nobile, V. Appay, G.P. Rizzardi, S. Fleury, M.
Lipp, et al. 2001. Skewed maturation of memory HIV-spe-
cific CD8 T lymphocytes. Nature. 410:106–111.
14. Macallan, D.C., C.A. Fullerton, R.A. Neese, K. Haddock,
S.S. Park, and M.K. Hellerstein. 1998. Measurement of cell
proliferation by labeling of DNA with stable isotope-labeled
glucose: studies in vitro, in animals and in humans. Proc. Natl.
Acad. Sci. USA. 95:708–713.
15. Neese, R.A., S.Q. Siler, D. Cesar, F. Antelo, D. Lee, L. Mis-
ell, K. Patel, S. Tehrani, P. Shah, and M.K. Hellerstein.
2001. Advances in the stable isotype-mass spectrometric mea-
surement of DNA synthesis and cell proliferation. Anal. Bio-
chem. 298:189–195.
16. Thiel, A., J. Schmitz, S. Miltenyi, and A. Radbruch. 1997.
CD45RA-expressing memory/effector Th cells committed
to production of interferon- lack expression of CD31. Im-
munol. Lett. 57:189–192.
17. Soares, M.V.D., N.J. Borthwick, M.K. Maini, G. Janossy, M.
Salmon, and A.N. Akbar. 1998. IL-7-dependent extrathymic
expansion of CD45RA T cells enables preservation of a na-
ive repertoire. J. Immunol. 161:5909–5917.
18. Schluns, K.S., W.C. Kieper, S.C. Jameson, and L. Lefrancois.
2000. Interleukin-7 mediates the homeostasis of naive and
memory CD8 T cells in vivo. Nat. Immunol. 1:426–432.
19. Fry, T.J., M. Moniuszko, S. Creekmore, S.J. Donohue, D.C.
Douek, S. Giardina, T.T. Hecht, B.J. Hill, K. Komschlies, J.
Tomaszewski, et al. 2003. IL-7 therapy dramatically alters pe-
ripheral T-cell homeostasis in normal and SIV-infected non-
human primates. Blood. 101:2294–2299.
20. Schonland, S.O., J.K. Zimmer, C.M. Lopez-Benitez, T.
Widmann, K.D. Ramin, J.J. Goronzy, and C.M. Weyand.
2003. Homeostatic control of T-cell generation in neonates.
Blood. 102:1428–1434.
21. O’Neill, R.M., J. Hassan, and D.J. Reen. 2003. IL-7-regu-
lated homeostatic maintenance of recent thymic emigrants in
association with caspase-mediated cell proliferation and apop-
totic cell death. J. Immunol. 170:4524–4531.
22. Harris, N.L., V. Watt, F. Ronchese, and G. Le Gros. 2002.
Differential T cell function and fate in lymph node and non-
lymphoid tissues. J. Exp. Med. 195:317–326.
23. Geginat, J., F. Sallusto, and A. Lanzavecchia. 2001. Cyto-
kine-driven proliferation and differentiation of human naive,
central memory, and effector memory CD4 T cells. J. Exp.
Med. 194:1711–1719.
24. Wherry, E.J., V. Teichgraber, T.C. Becker, D. Masopust,
S.M. Kaech, R. Antia, H. von Adrian, and R. Ahmed. 2003.
Lineage relationship and protective immunity of memory
CD8 T cell subsets. Nat. Immunol. 4:225–234.
25. Baron, V., C. Bouneaud, A. Cumano, A. Lim, T.P. Arstila,
L. Ferradini, and C. Pannetier. 2003. The repertoires of cir-
culating human CD8 central and effector memory T cell
subsets are largely distinct. Immunity. 18:193–204.
26. Hellerstein, M.K., R.A. Hoh, M.B. Hanley, D. Cesar, D.
Lee, R.A. Neese, and J.M. McCune. 2003. Subpopulations
of long-lived and short-lived T cells in advanced HIV-1 in-
fection. J. Clin. Invest. 112:956–966.
